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Abstract.  We have investigated the potential regula- 
tory role of TGF-B in the interactions of neurons and 
Schwann cells using an in vitro myelinating system. 
Purified populations of neurons and Schwann cells, 
grown alone or in coculture,  secrete readily detectable 
levels of the three mammalian  isoforms of TGF-B; in 
each case, virtually all of the TGF-/~ activity detected 
is latent.  Expression of TGF-BI, a major isoform pro- 
duced by Schwann cells, is specifically and signifi- 
candy downregulated as a result of axon/Schwann cell 
interactions.  Treatment of Schwann cells or Schwann 
cell/neuron  cocultures  with TGF-~I, in turn,  has dra- 
matic effects  on proliferation  and differentiation.  In the 
case of  purified  Schwann cells,  treatment with TOF-/31 
increases  their  proliferation,  and it  promotes a pre-  or 
nonmyelinating Schwann cell  phenotype characterized 
by increased NCAM  expression,  decreased NGF  re- 
ceptor expression, inhibition  of  the forskolin-mediated 
induction of  the myelin protein  P0, and induction of 
the Schwann cell transcription  factor suppressed cAMP- 
inducible POU protein.  Addition of TGF-/31 to the 
cocultures inhibits many of the effects of the axon on 
Schwann cells, antagonizing the proliferation induced 
by contact with neurons,  and,  strikingly, blocking my- 
elination.  Ultrastructural  analysis of the treated cul- 
tures confirmed the complete inhibition of myelination 
and revealed only rudimentary ensheathment of axons. 
Associated defects of the Schwann cell basal lamina 
and reduced expression of laminin were also detected. 
These effects of TGF-/?I  on Schwann cell differentia- 
tion are likely to be direct effects on the Schwann cells 
themselves which express high levels of TGF-/~I recep- 
tors when cocultured with neurons.  The regulated ex- 
pression of TGF-~  and its effects on Schwann cells 
suggest that it may be an important autocrine and 
paracrine mediator of neuron/Schwann cell interac- 
tions.  During development, TGF-~I  could serve as an 
inhibitor of Schwann cell proliferation and myelina- 
tion, whereas after peripheral  nerve injury, it may pro- 
mote the transition of Schwann cells to a proliferating, 
nonmyelinating phenotype, and thereby enhani:e the 
regenerative response. 
p 
ERIPHERAL nerve development  progresses through  a 
series  of distinct  stages  that  reflect  complex  and 
reciprocal interactions  between axons and Schwann 
cells (Webster,  1992). Initially, nerve fibers grow out essen- 
tially free of nonneuronal  cells. Subsequently, Schwann cells 
migrate and proliferate on the nerve fibers,  progressively 
subdividing  the nerve fascicle into smaller groups of nerve 
fibers.  Eventually,  Schwann  cells  either  communally  en- 
sheathe  multiple small  nerve fibers,  or they myelinate  in- 
dividual nerve fibers with which they have established a one- 
to-one relationship  (Webster,  1992). In both instances,  the 
axon/Schwann cell unit is surrounded by a basal lamina that 
is principally  synthesized by Schwann cells when they are in 
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contact with neurons (Bunge et al., 1982). This basal lam- 
ina,  in turn,  is required for the appropriate function  of the 
Schwann  cell;  defects  in basal lamina  production are as- 
sociated with defects in the ensheathment  and myelination of 
axons  (Bunge et al.,  1986). 
The different  anatomic relationships  that  Schwann cells 
establish  with axons  correspond to distinct  differentiated 
phenotypes.  Nomnyelinating,  ensheathing  Schwann  cells 
express high levels of  the adhesion molecules L1 and the neu- 
ral  cell adhesion  molecule (NCAM)  ~ do not express my- 
elin proteins,  and contain a distinct  set of cytoskeletal pro- 
teins.  By contrast,  myelinating  Schwann cells express low 
levels of NCAM and L1, but high levels of the myelin as- 
1.  Abbreviations  used in :his paper:  DRG, dorsal  root ganglion;  MAG, 
myelin-associated  glycoprotein; MBP, myelin basic protein; BrDU, 5-bromo- 
2'deoxyuridine; NCAM, neural cell adhesion molecule; SCIP, suppressed 
cAMP-inducible  POU protein;  MLEC,  mink lung epithelial  cells;  PAI, 
plasminogen activator inhibitor. 
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nents of the myelin sheath,  including myelin basic protein 
(MBP) and P0 (reviewed in Jessen and Mirsky, 1991; Salzer, 
1995).  Like proliferation and basal lamina  formation,  the 
differentiation of Schwann cells is regulated by the axon as 
their ensheathment fate is specified by the type of axon with 
which they are associated (Aguayo et al.,  1976; Weinberg 
and Spencer,  1976). 
After  injury,  there  are  dramatic  changes  in  peripheral 
nerves distal to the site of the lesion (reviewed in Fawcett and 
Keynes,  1990).  Expression of myelin proteins  rapidly de- 
clines  (Lernke  and  Chao,  1988)  and  Schwann  cells  re- 
express  NCAM  and  L1  (Martini  and  Schachner,  1988). 
Schwann cells also undergo a wave of proliferation at the site 
of injury in all nerves and in the distal stump of heavily my- 
elinated nerves (reviewed briefly in Salzer and Bunge, 1980). 
Concomitantly,  macrophages  invade the distal stump and, 
together with resident Schwann cells, they break down and 
clear the degenerating myelin (Stoll et al., 1989). Finally, if 
the nerve has not been permanently transected,  new nerve 
fibers sprout from the proximal end of the injured nerve and 
grow into the distal  stump guided by Schwann cells.  The 
downregulation  and  clearance  of myelin proteins  and  the 
reexpression of cell adhesion molecules by Schwann cells, 
together with their synthesis and release of neurotrophic fac- 
tors, is thought to be critical for successful regeneration of 
peripheral nerves after injury (Scherer and Asbury,  1993). 
The molecular signals that regulate Schwann cell prolifer- 
ation and differentiation  during  peripheral  nerve develop- 
ment  and  injury  are  not  well  understood.  Molecules  as- 
sociated  with  the  neuronal  surface  are  known  to  induce 
Schwann cell proliferation during development (Salzer et al., 
19g0), and they are likely to correspond, at least in part, to 
the recently described family of neuregulins (Marchionni et 
al., 1993), also referred to as glial growth factor and heregu- 
lin (Peles and Yarden, 1993). It is not yet known whether the 
mitogenic signals that stimulate Schwann cell proliferation 
during nerve injury are related to those that operate during 
development. However, a recent study reporting that soluble 
mitogenic factors are released as a result of injury (Wen et 
al.,  1994) suggests that they could be distinct. An additional 
potential source of mitogenic factors during nerve injury are 
macrophages, which invade the distal stump in high numbers 
and have been proposed to promote Schwann cell prolifera- 
tion during injury (Beuche and Friede, 1984) via soluble fac- 
tors (Baichwal et al.,  1988). However, the proliferation of 
Schwarm cells during Wallerian degeneration in vitro, in the 
absence of macrophages (Salzer and Bunge, 1980), suggests 
that  nonmacrophage-derived  mitogens,  potentially  growth 
factors released by the Schwann cells themselves,  are also 
likely to be important. 
Both proliferative and differentiative signals may be medi- 
ated via an increase in intracellular levels of cAMP. At low 
cell density, elevation of cAMP levels increases Schwann cell 
proliferation,  whereas  at  high  cell  densities,  particularly 
when proliferation is limited by growing cells in defined me- 
dia without serum, an increase in cAMP leads to an increase 
in the  expression  of myelin proteins  (Jessen and  Mirsky, 
1991; Morgan et al.,  199I). In view of these findings, treat- 
ment of Schwann ceils with the diterpene analogue forskolin, 
an activator of adenylate cyclase, has been used to mimic the 
effects of the axon on Schwann cells, particularly inducing 
the myelinating phenotype. Forskolin treatment, in addition 
to increasing  expression of myelin proteins,  also dramati- 
cally elevates the expression of the transcription factor SCIP 
(suppressed cAMP-inducible POU protein) by Schwann ceils 
(Monuki et al.,  1989).  This protein,  which was indepen- 
dently identified by several groups and is also called tst-1 (He 
et al.,  1990) and Oct-6 (Suzuki et al.,  1990), belongs to the 
POU domain  family  of transcription  factors.  It is promi- 
nently expressed by Schwann cells during periods of rapid 
proliferation,  i.e., during development and transiently after 
peripheral nerve injury (Monuki et al., 1990; Scherer et al., 
1994).  Its expression in vivo has also been inversely cor- 
related with the ability of Schwann cells to myelinate. There- 
fore, SCIP has been suggested to be a marker of, and may 
function  in,  proliferating,  premyelinating  Schwann  ceils. 
Consistent with this suggestion, SCIP inhibits the expression 
of myelin proteins, strongly repressing the P0 promoter, and 
also  inhibiting  the  expression  of the  p75  NGF  receptor 
(Monuki et al.,  1990). 
These studies suggest that there is an inverse relationship 
between Schwann  cell proliferation  and expression of the 
myelinating phenotype. Consistent with this notion, several 
Schwann cell mitogens,  notably FGF and members of the 
TGF-fl family  (Ridley et al.,  1989;  Davis and  Stroobant, 
1990; Schubert, 1992), have been reported to inhibit the ex- 
pression of myelin proteins induced by forskolin (Mews and 
Meyer, 1993; Rogister et al.,  1993; Morgan et al.,  1994). 
These results raise the possibility that these growth factors 
may have a role as inhibitors of Schwann cell myelination, 
although it is not known under what conditions and by which 
cells these growth factors are released.  In contrast,  axons 
may also release soluble factor(s) that promote the myelinat- 
ing phenotype, transiently inducing the expression of SCIP, 
for example, and leading to a several-fold increase in P0 ex- 
pression (Bolin and Shooter,  1993). These findings suggest 
that soluble mediators might function as both positive and 
negative regulators of Schwann cell myelination. 
In this study, we have investigated the role of TGF-/3s as 
mediators of axon/Schwann cell interactions. We focused on 
the TGF-/~s because of their critical role in regulating  cell 
growth and differentiation in many developing systems (Mas- 
sagu6, 1990; Sporn and Roberts, 1992) and their mitogenic 
effects on Schwann cells. The "I'GF-/~ family is comprised of 
three mammalian  isoforms termed TGF-fll,  -/32,  and -f13, 
and the TGF-/3  superfamily  contains,  in addition,  a  large 
number of homologous proteins (see Kingsley,  1994, for a 
recent review). We have principally focused on the role of 
TGF-ffl in this study because, as we now report, TGF-fll is 
a prominent isoform produced by Schwann cells, and the ex- 
pression of TGF-/31 appears to be regulated by axon/Schwann 
cell interactions.  We have found that TGF-fll,  which is a 
mitogen for purified Schwann cells, inhibits the proliferation 
of Schwann cells that is normally induced by neuronal con- 
tact. In addition, TGF-fll increases the expression of mark- 
ers of premyelinating  Schwarm cells,  notably NCAM and 
SCIP, and it inhibits the forskolin-induced transition to a my- 
elinating phenotype. Consistent with these findings, TGF-fll 
strikingly  inhibits myelination in Schwann cell/neuron co- 
cultures and leads to associated defects in the formation of 
the Schwann cell basal lamina.  These results indicate that 
TGF-/31 has  profound  effects on  the  axonal  induction  of 
Schwann cell proliferation and differentiation, and they sug- 
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proliferation  and  myelination  during  development.  These 
studies also suggest an important role for TGF-ffl in the re- 
generative  response that follows Wallerian degeneration  in 
the peripheral  nervous system. 
Materials and Methods 
Antibodies and Growth Factors 
Antibodies used in this study included anti-MBP and anti-PO polyclonal an- 
tibodies (gifts from D. Colman, Mount Sinai Medical Center, NY), a poly- 
clonal anti-p75 NGF receptor antibody (gift from Dr. B. Hempstead, Cor- 
nell University Medical Center, NY), monoclonal antibody MAS13 to the 
MAG (gift from M.  Schachner, Swiss Federal Institute of Technology, 
H6nggerberg, Ztirich), anti-Ll polyclonal antibody (gift from M. Grumet, 
New York University Medical School, NY), anti-NCAM polyclonal anti- 
body (gift from U. Rutishauser, Case Western Reserve University, Cleve- 
land, OH),  anti-SCIP polyclonal antibody (gift from M.  G.  Rosenfeld, 
University of California, San Diego, CA) and anti-laminin polyclonal anti- 
body  (Sigma  Chemical  Co.,  St.  Louis,  MO).  Neutralizing  antibodies 
against recombinant human TGF-/~I, native porcine "I'GF-/~2, and recom- 
binant chicken TGF-/33 were purchased from R & D Systems, Inc. (Min- 
neapolis, MN). A monoclonal antibody that neutralizes rat TGF-~I, TGF- 
/32, and TGF-~3 was purchased from G-enzyme Corp. (Cambridge, MA). 
Species-specific, affinity-purified,  rhodamine-conjugated donkey anti-rabbit 
IgG and fluorescein-conjugated donkey anti-mouse IgG were purchased 
from Chemicon International Inc. (Temecula, CA); fluorescein-conjugated 
mouse monoclonal antibodies directed against bromodeoxyuridine (BrDU) 
were obtained from Boehringer Mannheim Corp. (Indianapolis, IN). 
Recombinant human TGF-~I was a gift from Berlex Biosciences (South 
San Francisco, CA), recombinant human TGF-~2 was a gift from Celtrix 
(Santa Clara, CA), and TGF-B3 was purchased from R & D Systems. All 
concentrated stocks of  TGF-/3 were stored at 4°C in a solution of 5 mM HCI 
containing  1 mg/ml low endotoxin BSA (ICN Biomedicals, Inc., Costa 
Mesa, CA). 
~ssue Culture Methods 
Cultures of primary rat Schwann cells, dorsal root ganglion (DRG) neurons, 
and myelinating Schwann celI/DRG neurons were established as described 
previously (Einheber et al., 1993).  Briefly,  cultures of dissociated rat em- 
bryonic day 16 DRG neurons were grown on collagen-coated 12-ram glass 
coverslips in a four-well dish (Nunc, Naperville, IL) and cycled with antimi- 
totic agents in standard serum containing media to remove nonneuronal 
cells. The standard media consists of MEM (Whittaker Biopreducts, Inc., 
Walkersville, MD) supplemented with 10% FBS, 2 mM glntamine, 0.4% 
glucose, and 50 ng/ml 2.5S  NGF  (Bioproducts for Science, Inc., Indi- 
anapolis, IN)'. To establish myelinating cultures, DRG neuron cultures were 
seeded with 200,000 Schwann cells in standard media. Based on cell mor- 
phology, these Schwann cell preparations contained fewer than 0.1% fibro- 
blasts. On the next day, the standard media was replaced with N2 defined 
media (5 mg/ml insulin,  10 mg/ml transferrin, 20 nM progesterone, 100 
mM putrescine, 30 nM selenium, and 2 mM glutamine in a  1:1 mixture of 
DME  and  Ham's F-12  supplemented with 2.5S  NGF).  In this media, 
Schwann cells in contact with neurites proliferate in response to a neuronal 
mitogen, but they do not assemble a basal lamina or myelinate (Moya et 
ai., 1980).  The cultures were maintained in N2 media for 3 d to allow the 
Schwann cells to populate the neurites. To initiate basal lamina formation 
and myelination, the cultures were fed the standard media supplemented 
with 50 mg/ml ascorbic acid. 
Determination of TGF-{3 Activity 
Concentrations of total and active TGF-15 present in serum-free culture su- 
pernatants were measured using the plasminogen activator inhibitor-I pro- 
moter luciferase (PAI/L) assay as described (Abe et al., 1994). In this assay, 
serum-free culture conditioned superuatants are incubated with mink lung 
epithelial cells (MLEC)  stably transfected with an expression construct 
containing a portion of the TGF-/~-inducible plasminogen activator inhib- 
itor-I  (PAI-1) promoter fused to the firefly luciferase reporter gene. Ex- 
posure of the transfected MLEC to TGF-/3 results in a dose-dependent in- 
crease in luciferase activity in lysates of the cells, as measured with a 
luminometer. 
12 separate coverslips, each containing dissociated DRG neurons seeded 
with 200,000 Schwann cells, were maintained on N2 media for 3 d. Six of 
these cultures were switched to standard media (nonmyelinating cultures) 
and six to standard media supplemented with ascorbic acid (myelinating 
cultures).  Parallel  cultures  of neurons alone  and  Schwann cells alone 
(400,000 Schwann cells/collagen coated coverslip) were maintained as de- 
scribed for the nonmyelinating cultures.  (This number of Schwann cells 
represents an estimate of the minimum number of cells actually present in 
the cocultures based on cell counts from random fields). The cultures were 
fed their respective media every 2 or 3 d for a total of 8 d. The cultures 
were washed three times with N2 media, and they were incubated in 0.2 
ml of N2 media for an additional 2 d. The conditioned N2 media from each 
group of cultures was collected, pooled, and spun  10 rain at 4°C in a 
tabletop centrifuge to remove cellular debris. To determine the levels of to- 
tal TGF-B (active and latent), conditioned media were heated for 12 rain 
at 80°C to activate latent TGF-B. Active TGF-/3 levels were determined from 
unheated, undiluted conditioned media. Other samples were diluted to 20% 
with N2 media and added to the PAI/L-transfected  MLEC in 96-well plates. 
To determine the total amount of PAL1 promoter activity specifically in- 
duced by TGF-/3 in the samples, a neutralizing anti-TGF-/31,2,3 monoclonal 
antibody (20/~g/ml) was added to the diluted conditioned media and in- 
cubated with the transfected MLEC. The decrease in the amount of lucifer- 
ase expressed in the presence of this antibody (,x,75 % of the total luciferase 
in each case) was used to calculate the amount of active and total (active 
plus latent) TGF-/3 in the conditioned media. Similarly, the amount of PAI-1 
promoter activity induced by the individual TGF-/~ isoforms was determined 
by the addition of TGF-/31, -if2, or -/33 neutralizing antibodies (20 ~g/ml) 
to the assay. To generate standard curves of TGF-/3 isoform activity in the 
assay, serial dilutions of TGF-/~I, -/~2, or -/~3 (1.5-800 pg/mi) in N2 media 
were incubated with the transfected MLEC. After an overnight incubation 
at 37°C in a 5% CO2 incubator, the MLEC were washed with PBS and ex- 
tracted with iysis buffer (Analytical Luminescence Laboratory, San Diego, 
CA).  The cell lysates were analyzed for luciferase activity using lueif- 
erin substrate (Analytical Luminescence Laboratory) and a luminometer 
(ML1000;  Dynatech Laboratories Inc., Chantilly, VA). 
In parallel, we also performed a series of controls with each of the anti- 
bodies used in these assays to determine their specificity and efficiency in 
neutralizing each of the TGF-/~ isoforms. On average, the anti-TGF-~l,2,3 
monoclonal antibody inhibited 79%, 89%, and 83% of purified TGF4~I, 
TGF-/Y2, and TGF-B3,  respectively. The anti-'rGF-/31  antibody inhibited 
80%, 3%, and 5% of purified TGF-/~I, TGF-/T2, and TGF-33, respectively; 
the anti-TGF-ff2 antibody inhibited 3%, 92%, and 20% of purified TGF- 
/~1, TGF-/T2, and TGF-/~3, respectively; and the anti-'l'GF-/33  antibody in- 
hibited 6%,  39%,  and 94%  of purified TGF-~I,  TGF-/~2,  and TGF-/33, 
respectively. (Thus, the anti-TGF-/~l antibody was highly specific; the anti- 
bodies to TGF-ff2 and TGF-/33 displayed some cross-reactivity with recom- 
binant TGF-~3 and TGF-ff2, respectively). The calculated concentrations 
of TGF-/~ isoforms were corrected for this cross-reactivity. 
Effects of TGF-~I on the Expression of Schwann 
Cell Markers 
Primary  rat Schwann cells were expanded in tissue culture flasks (T-75 
Primaria; Falcon, Oxnard, CA) or poly-L-lysine-coated  flasks in D media 
(DME containing 10% FBS and 2 mM glutamine) supplemented  with 2/tM 
forskolin and 10/tg/ml crude glial growth factor prepared as described (Por- 
ter et al., 1986).  Once confluent, the cultures were maintained in D media 
for at least 7 d before addition of growth factors. To examine the effects of 
TGF-/31  and  forskolin  on  Schwann  cell  protein  expression,  flasks  of 
Schwann cells were fed with either N2 media or D media containing one 
of the following: 1 ng/ml TGF-/~1,  10 ng/mi TGF-/31, 10/tM forskolin, or 
a combination of 10 ng/ml TGF-~I and 10/tM forskolin for 7 d. Control 
cultures  were  fed  the  corresponding media  containing  an  appropriate 
amount of TGF-~I diluent. Cultures receiving N2 media or D media con- 
taining the added factors were fed either twice or three times, respectively, 
during the 7 d of treatment. In the N2 media experiments, three flasks were 
used for each treatment, and four flasks were maintained as controls. Only 
one flask was used per culture condition in the D media experiments. 
Expression of Schwann cell markers was determined by  immunoblot 
analysis of cell lysates. To prepare lysates, the cultures were washed with 
PBS, scraped into lysis buffer (95 mM NaC1, 25 mM Tris-Cl, pH 7.4,  10 
mM EDTA, 2% SDS, 1 mM PMSE and 10 mg/ml each of antipain, pepsta- 
tin A, and leupeptin), incubated in a boiling water bath for 5 rain, and then 
briefly sonicated. The lysates were spun in a microfuge to remove insoluble 
material, and the protein concentrations of the cleared supernatants were 
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IL). 75/~g of protein from each lysate was fractionated on a 5-15% SDS 
polyacrylamide gel and blotted onto nitrocellulose. Blots were incubated 
with primary antibodies followed by  125I-labeled protein A  (Amersham 
Intl.) and exposed for autoradiography. Quantitation of  the immunoreactive 
bands on the blots was performed on a Phosphorlmager (Molecular Dy- 
namics, Inc., Sunnyvale, CA). 
Effects of TGF-~I on Myelination 
To examine the effects of TGF-~I on the differentiation of Schwann cells, 
cocultures of Schwann cells and DRG neurons were grown under myelin- 
promoting conditions (standard media containing ascorbic acid) in the pres- 
ence or absence of 1 or 10 ng/mi TGF-~I. TGF-~I was added to cultures 
either when they were initially switched to myelin-promoting conditions or, 
alternatively, after they bad been maintained in myelinating conditions for 
2 d. The media for control cultures and cultures treated with 1 ng/ml TGF- 
l~l were supplemented  with the TGF-~I diluent (i.e., I mg/ml low endotoxin 
BSA in 5 mM HC1) equal in amount to that added to the cultures treated 
with 10 ng/ml TGF-~I. Cultures were subsequently given the standard me- 
dia containing ascorbic acid with or without TGF-~I every 2 or 3 d. After 
8 d of  growth under myelinating conditions, the cultures were processed for 
immunofluorescence or electron microscopy (described below). To deter- 
mine the number of myelin segments present in the control and TGF- 
/~l-treated cultures, the coverslips were immunostained for MBP and exam- 
ined by epifluorescence on a  microscope (Axiophot; Carl  Zeiss,  Inc., 
Thornwood, NY).  A  transparent grid was placed over the coverslips to 
facilitate counting the MBP-positive myelin segments on each coverslip. 
Statistical analyses were performed using the StatView program (Abacus 
Concepts, Inc., Berkeley,  CA). 
Effects of TGF-~I on Schwann Cell Proliferation 
The proliferation of Schwann cells grown in the absence or presence of neu- 
rons was determined using a BrDU nuclear labeling assay.  To investigate 
the effects of TGF-/31 on Schwann cells grown alone, 100,000 Schwann cells 
were plated onto poly-L-lysine-coated glass coverslips in standard media. 
The next day, the cultures were fed standard media with or without 1 or 10 
ng/ml TGF-~I; control cultures and cultures treated with 1 ng/mi TGF-/31 
were also supplemented with "rGtL01 diluent equal in amount to that added 
to the cultures treated with 10 ng/ml TGF-31. After •72  h, the culture media 
was supplemented with BrDU (10 ~tM final concentration). The cultures 
were incubated with BrDU in a 7% CO2 incubator at 35°C for 3.5 h. Cul- 
tures were washed in Dulbeoco's PBS, fixed in 100% methanol at -20°C for 
15 rain, and incubated in 2 N HC1 for 10-30 rain. The HCI solution was 
removed and the cultures neutralized by two 5-rain incubations in 0.15 M 
sodium borate buffer, pH 8.4, and several washes with LI5 media (GIBCO 
BRL, Gaithersburg, MD). The cultures were then blocked with LI5 media 
containing 10% serum for 30 rain, and they wore incubated with fhiores- 
cein-conjngated anti-BrDU antibody for 1 h at room temperature. Cover- 
slips were washed in PBS and mounted on glass slides in Citifluor (Citi- 
fluor Ltd., London, U.K.) containing 1 mg/ml Hoechst dye. 
The effects of TGF-~I on the proliferation of Schwann cells in coculture 
with neurons were also investigated. In these studies, neuron cultures were 
seeded with 200,000 Schwann cells in standard media and maintained in 
N2 media for an additional 3 d. The cultures were then fed standard media 
containing ascorbic acid to promote myelination. TGF-/31 was added to cul- 
tunes either when they were switched to myelin-promoting media or, alter- 
natively,  after they had been maintained in this media for 2 d. The BrDU 
proliferation assay was performed ,,o20 h after the addition of TGF-~ to 
the cultures. Proliferation assays were also performed on cocultures main- 
tained for 7 d in standard media after seeding neurons with Schwann cells. 
These cultures were switched to standard media containing ascorbic acid 
with or without TGF-/31 for 20 h before the proliferation assay was per- 
formed. 
BrDU- and Hoechst dye-labeled nuclei in random fields of  the coverslips 
were photographed using a Zeiss Axiophot microscope and slide film (Ek- 
tachrome 1601"; Eastman Kodak Co., Rochester, NY). At least five or six 
random fields were photographed, typically using a 20x  objective. The 
number of BrDU- and Hoechst dye-labeled nuclei in each field were then 
Counted in a blinded manner from the Ektachrome slides projected on a 
slide Viewer. In the case of Schwann cells grown alone, ',,1,500 cells per 
condition were counted; in the case of the Schwann cell/neuron cocultures, 
in excess of 2DO0 Cells per .condition  were counted. 
lmmunofluorescence Microscopy 
Cultures were processed for immunofluorescence microscopy as.described 
previously (Einheber et al.,  1993). 
Electron Microscopy 
Control  and  TGF-~l-treated  myelinating cultures,  grown  on  collagen- 
coated aclar plastic coverslips, were rinsed in PBS and fixed overnight at 
4°C in 0.05M sodium phosphate buffer, pH 7.0, containing 2% glutaralde- 
hyde and 0.1 M sucrose (Owens and Bunge, 1989).  After washing in 0.1 M 
phosphate buffer, the coverslips were incubated in 2% osmium tetroxide in 
0.1 M phosphate buffer for 1 h and embedded in Epon (Milner and Bacon, 
1989). Portions of  the coverslips were removed and reembedded in an orien- 
tation suitable for obtaining cross-sections of the cultures. Ultrathin sec- 
tions (50-65 nm) were collected on copper grids and counterstained with 
uranyl acetate and Reynold's lead citrate. Sections were analyzed on an elec- 
tron microscope (model 201; Philips Electronic Instruments Co., Mahwah, 
NJ). To confirm the extent of myelination of  the control and treated cultures 
used for ultrastructural analysis, additional cultures treated identically and 
in parallel to those used for ultrastructural analysis were immunostained for 
MBE and they were examined by immunofluorescence. 
To quantify the number of Schwann cell/neurite units with complete or 
patchy basal lamina in control and TGF-/~l-treated cultures, regions from 
at least two different coverslips for each condition were analyzed under the 
electron microscope. 
Identification of TGF-gl Receptors by Cross-linking 
TGF-~I  was iodinated using the IODO-GEN  iodination reagent (Pierce 
Chemical  Co.)  according to  the  manufacturer's  instructions.  Chemical 
cross-linking of iodinated TGF-/~I to cells was performed by a modification 
of described  procedures  (Wang  et  al.,  1991). For  these  experiments 
collagen-coated 35-ram  dishes were each plated  with  ,'~24  dissociated 
DRG's obtained from embryonic day 16 rat embryos. After cycling the cul- 
tures with antimitotic agents to remove nonneuronal cells, some of the col- 
tures were seeded with ,'ol  ×  106 Schwann cells per dish, and they were 
allowed to myelinate for 1 mo under standard conditions. The remaining 
neuron cultures were maintained in standard media. To perform the cross- 
linking reaction, cultures were washed four times with Dulbecco's PBS and 
incubated with binding buffer (Krebs-Ringer solution with 20 mM Hepes, 
pH 7.5,  0.5 mM MgSO4,  and 0.1% BSA) containing 25 pM  12SI-labeled 
TGF-t51 for 3 h at 4°C with gentle rotation. As a control for the specificity 
of the  TGF-~I  binding,  some cultures  were incubated with competing 
amounts of unlabeled TGF-~I (final concentration of 25 nM) in addition to 
the 25 pM 125I-labeled TGF-~I. The cultures were then washed four times 
in binding buffer without BSA at 4°C and then incubated in this buffer con- 
taining bis (sulfosuccinimidyl) suberate (BS  3) (Pierce Chemical Co.) at a 
final concentration of 62 ng/ml for 15 rain at 4°C with gentle shaking. The 
reaction was stopped by addition of Tris-HCl, pH 7.4, to a final concentra- 
tion of 100 raM. The reaction buffer was removed, and the cultures were 
resuspended in SDS gel sample buffer.  Samples were subjected to elec- 
trophoresis on a 7 % SDS polyacrylamide gel and then developed with the 
PhosphorImager. 
Statistical Analysis 
Statistical analyses were performed using the Statview program (Abacus 
Concepts, Inc.). All data were analyzed statistically by analysis of variance 
followed by the Bonferroni/Dunn post-hoc test, except in the case of the 
TGF-/5 levels, which were subjected to the Fisher's protected least signifi- 
cant difference post-hoc test. 
Results 
Expression of TGF-~ Isoforms by Schwann Cells 
and Neurons 
As a first step in analyzing the potential role of TGF-/~ in the 
interactions of Schwann cells and neurons, we measured the 
expression of each of the three TGF-/~ isoforms by these cell 
types. To this end, we used a sensitive bioassay (Abe et al., 
1994) to determine the levels of TGF-/3 in culture media con- 
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coculture. In this assay, conditioned media from the cultures 
were incubated with a  mink lung epithelial cell line stably 
transfected with an expression construct in which a TGF-/$- 
inducible promoter (i.e.,  a  portion of the PAI-1 promoter) 
was fused to a  luciferase reporter gene.  TGF-/3  stimulates 
these cells to synthesize luciferase in a dose-dependent man- 
ner. During incubation with the MLEC, we also added a se- 
ries of commercially available neutralizing antibodies to the 
conditioned media. One antibody blocked the activity of all 
three  TGF-/~  isoforms;  the  other  antibodies  were  isoform 
specific.  The decrease in the amount of luciferase synthe- 
sized in the presence of these antibodies represented TGF- 
/S-specific activity. 
Using this assay, we first determined the concentration of 
total (latent plus active) and active TGF-/3  in media condi- 
tioned by DRG neurons, Schwann cells, and neuron/Schwann 
cell cocultures under myelinating (serum plus ascorbic acid) 
and  nonmyelinating  (serum  alone)  conditions.  Results  of 
three  separate experiments are  summarized in  Fig.  1.  We 
found  significant and comparable amounts of total TGF-/3 
activity expressed by each cell type, with the most activity 
in  the  cultures  of  neurons  and  the  least  activity  in  the 
Schwann  cell/neuron  cocultures.  Very  little  active TGF-/3 
was detected in any of the cultures, with active levels consis- 
tently measured in the 4-5 pg/ml range compared to total 
levels in the 300-500 pg/ml range. Thus, in each case, the 
majority of the TGF-~ activity present in the culture media 
is latent.  Using isoform-specific antibodies,  we also deter- 
mined which of the three mammalian TGF-/~ isoforms are 
released by these cells. These studies demonstrated that all 
three TGF-/3 isoforms are released by neurons and Schwann 
cells,  with  the  proportions varying by cell type.  Neurons 
principally release TGF-/~2 and -/~3, whereas Schwann cells 
principally release TGF-/~I  and -/~2. The amount of the in- 
dividual isoforms, when added together, exceeded the amount 
independently measured with an anti-TGF-/~l,2,3 monoclo- 
nal antibody potentially reflecting less efficient inhibition of 
each isoform with this antibody. Of  particular note, the levels 
of TGF-~, as a proportion of the TGF-/~ activity, drop sig- 
nificantly in the neuron/Schwann cell cocultures in compari- 
son to the levels of TGF-~I in the Schwann cell cultures. By 
contrast, the levels of TGF-/~2 are similar in each case, and 
the relative levels of TGF-/~3  are elevated in the cocultures 
compared to Schwann cells alone. These results suggest that 
there is a differential regulation of TGF-/$ isoforms. TGF-/~I 
expression appears to be specifically downregulated as a re- 
sult of coculture, suggesting it may have a role in mediating 
axon/Schwann cell interactions. 
TGF-[31 Promotes NCAM and SCIP Expression and 
Antagonizes the Effects of Forskolin on Schwann Cells 
To examine the potential significance of the regulated expres- 
sion of TGF-/~I  in these cultures,  we first characterized its 
effects on the expression of Schwann cell markers. For these 
studies, we grew Schwann cells in media, with or without se- 
rum, containing 1 or 10 ng/ml of TGF-/~I, 10/xM forskolin, 
10 #M forskolin with 10 ng/ml of TGF-~I, or without supple- 
ments (control). As previously noted (Rogister et al., 1993), 
TGF-/~ dramatically alters the morphology of Schwann cells. 
Thus, cells treated with TGF-/3, with forskolin, or with both 
Figure 1.  TGF-/~ levels in Schwann cells,  neurons,  and Schwann 
cell/neuron  cocultures.  Conditioned  serum-free  media were col- 
lected  from  cultures  of  neurons,  Schwann cells,  and  neuron/ 
Schwann cell cocultures  that  had previously been maintained  in 
media  containing  serum (N+Sc:S) or serum plus  ascorbic  acid 
(N+Sc:S+A) to promote myelination. Total levels of TGF-/3, TGF- 
~1, TGF-/32, and TGF-/33 were determined in three separate experi- 
ments;  standard  error bars are shown. Individual TGF-/~ isoform 
levels shown were corrected  for cross-reactivity  of the  isoform- 
specific antibodies, as described in the Materials and Methods. The 
levels of TGF-~, relative to the TGF-/3 activity, are significantly 
less  in  the  neuron/Schwann  cell  cocultures  compared  to  the 
Schwann cell cultures (P < 0.005), whereas the relative TGF-#3 ac- 
tivity  is significantly greater (P < 0.05). 
Figure 2. Effect of TGF-/~I  on Schwann cell markers. Schwann cells 
were grown in serum containing media supplemented with either 
1 ng/ml of TGF-/~I (T/), 10 ng/ml of TGF-~I (T/0), 10 #M forsko- 
lin (F), or 10 ng/ml of  TGF-/~I  plus 10 #M forskolin (F+T). Lysates 
were  prepared,  fractionated  by  SDS-PAGE, and  blotted.  The 
nitrocellulose blot was cut into strips that were probed with anti- 
bodies to LI (which recognized bands of 220 and 200 kD), NCAM 
(140 and 120 kD), the NGF receptor (75 kD), SCIP (40 kD), and 
P0 (25 kD).  After incubation with the primary antibodies,  each 
strip was incubated with t25I protein A and exposed for autoradi- 
ography. 
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pearance than control cells and appeared to be more fre- 
quently in contact with one another (data not shown). In ad- 
dition, although not specifically investigated, Schwann cell 
survival after 1 wk appeared to be better in the defined media 
supplemented with TGF-/31 or forskolin than in the defined 
media alone. At 1 wk, Schwann cell lysates were prepared 
and analyzed by Western blotting to quantitate the effect of 
TGF-/$ and forskolin on the expression of  L1, NCAM, the p75 
NGF receptor, the transcription factor SCIP, and the myelin 
protein P0. An example of a typical Western blot is shown 
in Fig. 2, and results from several such experiments are sum- 
marized in Table I. 
In general, addition of TGF-~ appears to promote a pre- 
or nonmyelinating Schwann cell phenotype. Thus, treatment 
with high or low concentrations of TGF-~ resulted in in- 
creased expression of NCAM, which is present on nonmye- 
linating Schwann cells. TGF-/~I also generally suppressed 
the basal expression of the myelin protein P0 and inhibited 
its induction by forskolin. TGF-~I also reduced expression 
of the  NGF  receptor  and  of L1  (particularly  in  serum- 
containing media). The magnitude of the effects of both for- 
skolin and TGF-/31 on Schwann cells was generally not as 
pronounced in the presence of serum, consistent with other 
studies (Morgan et al.,  1994).  Of particular note, we ob- 
served a consistent and substantial induction of SCIP expres- 
sion by TGF-/31, both in the presence and absence of serum 
(see Fig. 2). The basal level of SCIP expression in Schwann 
cells grown in media without serum appeared to be lower 
than in cells grown with serum which may account, in part, 
for the generally greater induction of SCIP expression ob- 
served with forskolin under defined media conditions (data 
not shown). 
In other studies, we found that TGF-/31 had no effect on the 
expression of NCAM and L1 by neurons that were similarly 
treated (data not shown), indicating that these effects were 
specific to Schwann cells in this system. 
TGF-[3 Inhibits Schwann Cell Myelination 
The effect of TGF-~I  on Schwann cell markers described 
Table II.  TGF-f31 Inhibits Schwann  Cell Myelination 
Number of myelin 
Day of TGF-/31  Concentration of  segments per 
addition  added TGF-B1  coverslip  Inhibition (%) 
ng/ml 
0  0  2,943  5:567  - 
0  1  671  5:61  77.2 
0  10  0  5:0  100 
2  10  5  5:0,5  99,8 
The number of myelin segments was determined in Schwann celI/DRG eoeul- 
tures grown in the absence or presence of 1 or 10 ng/ml TGF-/~I.  The TGF-/$1 
was either added at the time the cultures were switched to standard media con- 
raining ascorbic acid (day 0) or after the cultures had been maintained in this 
media for 2 d (day 2).  After a total of 8 d of growth under myelin-promoting 
conditions, the cultures were fixed and the number of MBP-positive segments 
was determined, The mean values and SEM presented are from the myelin 
counts of four day 0 cultures at each concentration and two day 2 cultures from 
a representative experiment. The number of myelin segments in the day 0 con- 
trol cultures was significantly different  from that of the cultures treated  with 
TGF-/~I  on day 0 and day 2 (P <  0.001). 
above suggested that TGF-~I might antagonize the differenti- 
ation of Sehwann cells toward the myelinating  phenotype. To 
investigate this possibility directly,  we  added  TGF-/~I to 
cocultures of neurons and Schwann cells, and we character- 
ized the extent of myelination after 1 wk. Results of a typical 
experiment are shown in Fig. 3, and they are summarized in 
Table II. While untreated cocultures extensively myelinated 
(Fig. 3 A), addition of 10 ng/ml of TGF-/31 completely in- 
hibited myelination (Fig. 3 E). Although no myelin sheaths 
were present in the treated cultures, we often observed a 
small amount of  particulate staining for MBP in the Schwann 
cells, suggesting there may be some residual synthesis. In ad- 
dition, as will be considered further below, there appeared 
to be significantly fewer Schwann cells in the treated cultures 
compared to the controls (Fig. 3, F vs B). Even after several 
weeks of TGF-'/~I treatment, no myelin was observed in any 
of the cultures treated with 10 ng/ml (data not shown), indi- 
cating that there was a complete inhibition of myelination. 
This effect was not limited to TGF-/~I, since treatment of 
Table L  Effect of TGF-fll and Forskolin on the Expression  of Schwann  Cell Markers 
A Defined media 
LI  NCAM  NGFR  SCIP  P0 
T1  1.48  5:0.10  3.45  5:0.85  0.76  5:0.06  1.77  5:0.42  2.70  5:0.95 
TI0  0.87  5:  0.03  6.37  5:  2.31  0.50  5:  0.06  3.10  5:  0.66  0.73  +  0.23 
F  0.53  5:0.03  2.85  5:1.05  0.77  5:0.18  35.03  5:12.88  8.20  5:1.19 
F+T  0.70  5:  0.12  4.90  5:  1.73  0.73  5:  0.12  13.30  5:  4.40  5.33  +  1.96 
B Serum-containing media 
L1  NCAM  NGFR  SCIP  P0 
TI  0.75  5:0.05  1.56  5:0.09  0.84  5:0.04  2.19  5:0.46  0.62  5:0.03 
T10  0.44  5:0.08  1.63  +  0.15  0.54  5:0.04  8.74  5:5.06  0.53  d:  0.11 
F  0.30  5:0.01  0.98  5:0.18  1.03  5:0.01  8.38  5:5.27  2.36  +  0.06 
F+T  0.43  +  0.04  2.07  5:0.47  0.56  5:0.02  3.40  5:1.45  1.01  5:0.10 
Primary Schwann cells were grown in defined media (A) or media containing 10% fetal calf serum (B) with TGF-/51 at 1 ng/ml (T1) or 10 ng/ml (TIO), 10 tLM 
forskolin (F), or forskolin plus 10 ng/ml of TGF-/31 (F+ T). The expression of LI, NCAM, the p75 NGF receptor, PO, and SCIP were determined by Western 
blotting, and they are given relative to levels in untreated (control)  Schwann cells grown in the same media..Mean values and SEM from three to six determinations 
are presented in A, and mean values and range from duplicate determinations are presented in B. 
The Journal of Cell Biology, Volume 129,  1995  448 Figure 3.  TGF-/31 inhibits myelination. A control culture (A and B) and cultures treated with 1 ng/ml of TGF-/31 (C and D) or with 10 
ng/ml of TGF-/31 (E and F) immediately after adding media that promotes myelination and a culture treated with 10 ng/ml of TGF-/31 
commencing 48 h after adding such media (G and H) are shown. Panels on the left side of  the figure (A, C, E, and G) are immunofluorescent 
micrographs of the cultures stained for myelin basic protein; the identical fields demonstrating Schwann cell nuclei stained with a nuclear 
dye are shown on the right (B, D, F, and H). Note that there are significantly fewer Schwann cells in the TGF-/31-treated  cultures. Bar, 
100 ~m. cocultures with 10 ng/ml of TGF-/32 also resulted in a com- 
plete inhibition of myelination in the coculmres (data not 
shown).  Addition  of  1  ng/ml  TGF-/31 to  the  cocultures 
significantly inhibited myelin formation as well, although the 
inhibition was incomplete (Fig. 3 C). In three separate ex- 
periments, the average number of myelin segments in cul- 
tures treated with 1 ng/ml was reduced from 66 % to >90 %. 
After several weeks, cultures treated with I ng/ml of  TGF-/~I 
did eventually myelinate quite extensively suggesting that, at 
this concentration, the principal effect of TGF-~I is to delay 
the process of myelination. 
To determine whether there was a critical window for the 
inhibitory effects of TGF-/~I on myelination, we added TGF- 
fll at varying times of Schwann cell/neuron coculture. In one 
set of studies, we pretreated the Schwann cells with 10 ng/ml 
of TGF-/31 for 1 wk before adding them to cultures of neu- 
rons. Alternatively, we pretreated the neurons for 1 wk, re- 
moved the TGF-/~I, and then inhibited any residual TGF-/31 
with a pan-TGF-/3 blocking antibody or by brief trypsiniza- 
tion before adding Schwann cells. In both cases, cocultures 
subsequently  myelinated  comparably  to  control  cultures 
(data not shown). These results indicate that TGF-/31 does 
not irreversibly block the ability of Schwann cells to form 
myelin. We next added TGF-/~I at various times after estab- 
lishment of  the cocultures. We previously noted that 3 d after 
switching cocultures to medium supplemented with serum 
and ascorbate, the first myelin sheaths are detectable by im- 
munofluorescence; many of  the remaining Schwann cells ap- 
pear to be in an ensheathing or premyelinating relationship 
with axons (Einheber et al., 1993). Strikingly, addition of 10 
ng/ml of TGF-/~I just before the onset of myelination, i.e., 
48 h after switching to media supplemented with serum and 
ascorbate, also effectively blocked myelination in the cocul- 
rares (see Fig. 3 Gand Table H). In preliminary experiments, 
addition of TGF-/31 as late as 5 d after coculture appeared 
to profoundly inhibit myelin formation (data not shown), 
suggesting that Schwann cells in an early stage of myefina- 
tion are still efficiently inhibited by TGF-~I. By contrast, 
once extensive amounts of myelin have formed (i.e., after 1 
wk of coculmre), treatment with TGF-/~I for an additional 
week or longer did not result in appreciable degeneration of 
myelin sheaths that had already formed (data not shown). 
Taken together, these results indicate that TGF-/~I must be 
present during the period of active myelination to inhibit this 
process effectively,  pretreatment does not irreversibly inhibit 
Schwann cells from forming myelin, nor does short term 
treatment cause breakdown of mature myelin sheaths that 
have already formed. 
TGF-{$ Results in IX,  fects of  Schwann Cell 
Ensheathment and Basal Lamina Formation 
To  determine  more  precisely  the  effect  of  TGF-/31 on 
Schwann cell ensheathment and myelination, we performed 
an ultrastructural analysis of  cocultures of Schwann cells and 
Figure 4.  Ultrastructure of control and TGF-~l-treated cultures. 
Electron micrographs of  control (.4) and TGF-B-treated cultures (B 
and C). The culture shown in B was treated with 10 ng/ml of TGF- 
~1 from the time the culture was switched to media promoting my- 
elination; TGF-/~  was added to the culture shown in C 2 d after 
switching to this media. Large neurites (n) that are myelinated or 
loosely wrapped are visible in the control culture; similar sized 
neurites  are only partially  segregated off in B, or they are en- 
sheathed together with small nerve fibers in C. An area of patchy 
basal lamina present in the TGF-/~-treated  culture in B is indicated 
by the arrowheads. Bar, 0.5/tm. 
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Lamina Formation 
Day of  Number of 
TGF-/~ 1  Concentration  Schwann cells 
addition  of add~ TGF-BI  examined 
Percent of Sehwann cells 
with a basal lamina 
Complete  Partial  Absent 
ng/ml 
0  0  229  68.6  31.4  0 
0  10  165  15.2  80.6  4.2 
2  10  205  59.5  40.5  0 
The extent of basal lamina formation in Schwann celI/DRG cocultures grown 
in the absence or presence of 10 ng/ml TGF-/~I was determined from electron 
rnicrographs. The TGF-BI  was added either at the time the cultures were 
switched to standard media containing ascorbic acid (day 0) or after the cul- 
tures had been maintained in this media for 2 d (day 2). After 8 d of growth 
under myelinating conditions, the cultures were fixed and processed for elec- 
urn microscopy. The Schwann cell basal lamina was scored as complete if it 
formed a continuous, uninterrupted layer around Schwann cells associated with 
neurites. The percentage of Schwann cells with complete basal lamina in the 
control cultures and cultures treated with 10 ng/ml of TGF-B1  on day 2 was 
greater than in the cultures treated with TGF-OI on day 0  (P <  0.0(D1). 
neurons maintained with or without 10 ng/ml of'rGF-/~l for 
8 d  (see Fig. 4).  Cultures treated with  10 ng/ml TGF-B1 
demonstrated a variety of abnormalities when compared to 
control cultures, including defects of ensheathment, com- 
plete failure to form myelin, and partial defects of basal lam- 
ina formation (Fig. 4 B). In the treated cultures, Schwann 
cells typically extended relatively short processes into the 
nerve fiber bundles and only partially separated nerve fibers. 
By light microscopy, this abnormality of ensheathment ap- 
peared to be more prominent in the center of the coverslip, 
where bundles of unensheathed fibers were frequently ob- 
served, than in peripheral regions where there were more 
Schwann cells (data not shown). However, ensheathment was 
clearly abnormal and more rudimentary in the periphery 
compared to control cultures. In addition, the rough ER was 
quite prominent in many of the treated Schwaun cells which 
frequently contained cisternae of swollen ER decorated with 
ribosomes (see Fig. 4 B). Finally, the amount of  basal lamina 
formed by TGF-B-treated Schwarm cells appeared to be thin- 
ner and less complete than in control cultures. Schwarm cells 
containing only a partial basal lamina were much more com- 
mon in the treated cultures than in the control cultures, and 
cells devoid of any basal lamina were present in the treated 
cultures, but not in the control sections that were analyzed. 
These effects of'rGF-~l on basal lamina formation are quan- 
titated in Table ill. 
We also examined the morphology of cocnltures treated 
with 1 ng/ml of TGF-/~I, as well as cocultures placed on 10 
ng/ml after 2 d of culture in the presence of serum and astor- 
bate. In general, cultures treated with 1 ng/ml of TGF-/5'I 
demonstrated defects sinailar to those described above,  al- 
though the abnormalities were not as pronounced. Ensheath- 
ment of nerve fibers had progressed further, occasional my- 
elinated fibers were encountered, and defects of the basal 
lamina were not as severe (data not shown). Cultures that 
were treated with 10 ng/ml of TGF-~I after a 2-d delay, al- 
though appearing to  ensheathe more  normally, still con- 
tained very few myelinated fibers. This failure to myelinate 
may reflect the fact that fewer large diameter neurites ap- 
peared to be segregated off  in a 1:1 relationship with Schwann 
cells in comparison to control cultures (see Fig. 4 C). Of 
particular note, the Schwann cell basal lamina in these cul- 
tures was comparable to controls (see Table m). Therefore, 
these results suggest that the ability of TGF-/~I to inhibit my- 
elination in these cultures is likely to be independent of its 
effects on basal lamina formation. 
To  analyze further the  basal  lamina defect in  cultures 
treated with TGF-B1, we stained control and treated cultures 
with a polyclonal anti-laminin antibody 1 wk after adding 
ascorbic acid (shown in Fig.  5).  In the control cultures, 
Schwann cells were actively myelinating and expressed read- 
ily detectable levels of MAG (Fig. 5 C). Expression of lami- 
nin by these early myelin segments was quite robust, and 
localized at the outer surface of myelin sheaths, as well as 
that of Schwann cells that had just begun to myelinate (Fig. 
5  E);  nonmyelinating Schwann  cells  were  also  brightly 
stained, demonstrating a more fibrillar pattern of expression 
over their surface. By contrast, the pattern of laminin stain- 
ing in the treated cultures, while generally similar, was nota- 
bly attenuated and less distinct (Fig. 5 F). Schwann cells also 
appeared to be larger and more flattened in the treated cul- 
tures (Fig. 5 B), and they did not stain with MAG antibodies 
(Fig.  5 D).  These results suggested that TGF-/3 inhibited 
laminin expression. To quantitate this effect, we analyzed the 
expression of laminin in treated and control cocultures by 
Western blot analysis. As shown in Fig. 6, the total amount 
of laminin present in the treated cocultures was significantly 
reduced. Quantitative analysis indicated that treated cultures 
contained ,~50% of the amount of laminin present in control 
cultures; in contrast, tubulin expression in these cultures was 
comparable (data not shown). It is of interest that the laminin 
antibody only recognized one or both of  the laminin/~ chains 
in the treated and control cultures, but not the ~ chain, in- 
dicating that the major laminin component in these cultures is 
not laminin-1,  but  rather,  a  laminin isoform.  In prelimi- 
nary studies, we have detected both c~2 (merosin) and/~2 
(S-laminin) chains in these cultures, with o~2 levels in partic- 
ular showing a significant decrease in the TGF-B-treated cul- 
tures (data not shown). 
TGF-[31 is a Mitogen for Purified Schwann Cells, 
but it Inhibits the Proliferation  of Schwann Cells in 
Coculture with Neurons 
In view of previous reports that TGF-~ is a  Schwann cell 
rnitogen (Eccleston et al.,  1989;  Ridley et al.,  1989),  we 
were surprised to note that there were consistently fewer 
Schwann cells in the cocultures treated with TGF-B1 than in 
the control cultures (see Fig. 3). These results suggested that 
TGF-/3 might have a  paradoxical inhibitory effect on the 
proliferation of Schwann cells induced by neurons. To test 
this possibility, we compared the effect of TGF-/3 on the 
proliferation  of purified  Schwann  cells  to  the  effect on 
Schwann cells cocultured with neurons. Consistent with ear- 
lier reports, we found that TGF-/~I is a mitogen for purified 
Schwann cells, resulting in a nearly seven-fold increase in 
their labeling index (see Table IV). By contrast, TGF-~I is 
a  strong antagonist of the proliferation induced by contact 
with neurites, reducing the labeling index by ,~60%  at  1 
ng/ml and by ,x,75  % at 10 ng/ml; a representative experiment 
is shown in Fig. 7, and several such experiments are summa- 
rized in Table V. This inhibition of proliferation in the co- 
Einheber et al.  TGF-fl I Regulates  Axon/Schwann  Cell Interactions  451 Figure 5. Laminin staining of TGF-Bl-treated cultures. Control cultures (A, C, and E) or cultures continuously treated with TGF-~I at 
10 ng/ml (B, D, and F) were fixed after 1 wk and visualized by Nomarski optics (A and B), or they were immunostained for MAG (C 
and D) or laminin (E and F). Bar, 25/~m. 
cultures was observed when TGF-~  was  added in media 
containing serum plus ascorbic acid (SA media) either im- 
mediately upon  switching  from serum-free media to  SA 
media (condition A) or 2 d after such a switch (condition B). 
We also maintained the cocultures in media with serum but 
not ascorbic acid for 1 wk to allow Schwann cells to repopu- 
late neurites partially while preventing basal lamina forma- 
tion or myelination (Fernandez-Vall~  et al.,  1993); we then 
added the TGF-BI  in SA media (condition C).  Under all 
three conditions, TGF-/31 significantly inhibited proliferation 
and any subsequent myelin formation. In addition, prolifera- 
tion of Schwann cells was also reduced in coculmres main- 
rained in serum-free defined media in the presence of TGF- 
/31 (data not shown). Thus the effects of TGF-B1 on Schwann 
cell proliferation strikingly differ, depending on whether or 
not Schwann ceUs are associated with nerve fibers. 
This effect of TGF-BI on Schwann cell proliferation raised 
the possibility that the cultures treated with TGF-~ failed to 
myelinate because of insufficient numbers of Schwann cells. 
In an effort to distinguish between the effect of TGF-~I on 
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laminin  expression.  Lysates 
from control neuron/Sehwarm 
cell cultures (b) or cocultures 
treated with 1 ng/ml of TGF- 
~1 (c) or 10 ng/ml of TGF-~I 
for 1 wk (d) were prepared, 
fractionated, and probed with 
an antilaminin  polyclonal anti- 
body, incubated with n5I pro- 
tein A, and visualized by auto- 
radiography. In lane (a), 0.4 ttg 
of larninin is shown for com- 
parison.  Note that the upper 
band (artvg~ad) correspond- 
ing  to the  laminin  c~ chain, 
which is present in the laminin control,  is not expressed by the 
neuron/Sehwarm cell cultures. Also, the 3 chains (asterisk) are of 
lower relative molecular mass in the cocultures. 
Schwann  cell  proliferation and  differentiation,  we  plated 
Schwann cells onto cultures that contained a third fewer neu- 
rons than our typical paradigm before adding TGF-31. Under 
these conditions, the ratio of Schwann cells to neurons was 
extremely high, and the number of Schwann cells in the con- 
trol and treated cultures were comparable when ceils were 
visualized with a dye that stains cell nuclei (data not shown). 
Nevertheless, no myelin was observed in any of the cultures, 
suggesting the effects of TGF-/~I on myelination are indepen- 
dent of its effects on proliferation. 
Expression of TGF-f3  Receptors in Cocultures of 
Schwann Cells and Neurons 
To identify whether neurons, Schwann cells, or both were 
targets of these effects of TGF-/~, we determined the pattern 
of TGF-3 receptor expression by cross-linking with  iodi- 
nated  TGF-/~I.  Cultures  of neurons  alone  or  myelinating 
cocultures were incubated with radioactive TGF-/31 and then 
briefly treated with the homobifunctionai crosslinker BS  3. 
Lysates were then prepared, fractionated by SDS-PAGE, and 
exposed with a Phosphorlmager. Results are shown in Fig. 
8. In the Schwann cell/neuron cocultures, bands correspond- 
ing in size to ,,o70, 85,  and a broad band from 200 to 250 
kD were strongly labeled and readily apparent (Fig. 8, lane 
c). These bands correspond in size to TGF-3 type I, type II, 
and  type HI receptors,  respectively, that  were previously 
defined in other systems by similar techniques (Wang et al., 
1991). Specificity of this cross-linking pattern was indicated 
by the ability of excess, unlabeled TGF-31 to block essen- 
tially all labeling (Fig. 8, lane d). By contrast to the strong 
expression of receptors in these cultures, very little labeling 
of receptors was observed in the cultures of neurons alone. 
As most of the neurons are likely to be either ensheathed or 
myelinated by Schwann cells in these mature cocultures, and 
in view of  the minimal expression of receptors in the neuron 
cultures,  these  results  suggest that  Schwann cells are the 
principal cell type expressing TGF-/~ receptors in the cocul- 
tures. This result is consistent with the effect of TGF-/~I on 
Schwann cell markers  (Table I)  in  contrast to  its  limited 
effect, if any,  on neurons. 
Table IV.  TGF-f31 Stimulates Schwann Cell Proliferation 
in the Absence of Neurons 
Concentration 
of added TGF-~ 1  Percent of BrDU-positive cells 
ng/ral 
0  0.9  5:0.4 
1  6.3  5:1.4 
10  5.9 5:1.2 
Proliferation assays were performed on cultures of Schwarm cells maintained 
for 72 h in standard media with or without TGF-~I. The percent of BrDU- 
positive cells after a 3-h pulse was determined from three or four coverslips 
per condition  from a representative  experiment;  mean values and  SEM are 
shown.  The percent of BrDU-positive cells  in the control  cultures  was sig- 
nificantly different from that of the cultures treated with 1 ng/ml and 10 ng/ml 
TGF-~I (P <  0.05). 
Table V.  TGF-[31 Inhibits Schwann Cell Proliferation 
Induced by Coculture with Neurons 
Concentration of added 
Condition  TGF-/31  Percent of BrDU-positive cells 
ng/ml 
A  0  22.4  +  0.3 
1  7.7  5:1.0 
10  6.4  5:0.6 
B  0  13.5  5:3.2 
1  6.1  5:1.5 
10  3.0 5:0.7 
C  0  9.0 5:0.5 
10  1.5 5:0.3 
The effect of TGF-/}I on the proliferation of Schwann cells in coeuiture with 
neurons was determined under three different culture conditions. In condition 
A, neurons seeded with Schwann cells were maintained in a defined media for 
3 d,  and then  switched to standard  media containing  ascorbic  acid  with or 
without TGF-#1 for 20 h. In condition B, Schwann cell/neuron cocultures were 
grown in a defined media for 3 d and standard media containing ascorhic acid 
for 2 d before  addition of the TGF-#I. In condition C, the cocultures were 
maintained in standard media for 7 d, and then switched to standard media con- 
taining aseorbic acid with or without TGF-B1. The percent of BrDU-positive 
cells after a 3-h labeling period  was determined  from duplicate or triplicate 
coverslips from representative experiments for conditions A and B and from 
six coverslips for condition C; mean values and SEM are presented. In all three 
conditions, the percent of BrDU-positive cells in the control cultures were sig- 
nificantly  different than  those  of cultures  that  were treated  with  10  ng/ml 
TGF-/~I (P < 0.05). 
Discussion 
In this paper, we have investigated the expression of TGF-/3 
by neurons and Schwann cells, and we have characterized the 
effect of TGF-ffl, an abundant isoform produced by Schwann 
cells,  on  their proliferation and  differentiation.  We  have 
found  that  TGF-/31, which  induces  the  proliferation  of 
Schwann cells grown alone, dramatically inhibits the prolif- 
eration, myelination, and basal lamina formation of Schwann 
cells in coculture with neurons. These results suggest that 
TGF-B1 may be an important mediator of axon/Schwann cell 
interactions, regulating Schwann cell proliferation and dif- 
ferentiation during development and, as will be discussed, 
after nerve injury. 
Expression  of TGF-[3 Isoforms by Schwann Cells 
and Neurons 
We have obtained compelling evidence that both Schwann 
Einheber et al.  TGF-3 I  Regulates  Axon/Schwann  Cell Interactions  453 Figure 7. TGF-B1 inhibits Schwarm  cells proliferating on neurites. Schwann cells were seeded onto cultures of sensory neurons, maintained 
in defined media, and then switched to SA media without TGF-B1 (A and B) or with 1 ng/ml of TGF-B1 (C and D) or 10 ng/ml of TGF-B1 
(E and F). After 24 h, BrDU was added for 3 h and cultures were fixed and stained with an anti-BrDU antibody (A, C and E), or the 
same fields were visualized with a nuclear dye (B, D, and F). Bar,  100 #m. 
cells and  sensory neurons  synthesize all three TGF-# iso- 
forms,  although  the  proportions  vary by cell  type.  Thus, 
Schwarm cells secrete a higher proportion of TGF-~I and -/32 
compared to neurons that express relatively more TGF-/32 
and -/33. This work significantly extends previous investiga- 
tions on the expression of TGF-/3 isoforms by neurons and 
Schwarm cells in the peripheral nerve (Flanders et al.,  1991; 
Unsicker et al.,  1991;  Scherer et  al.,  1993)  and  in  vitro 
(Mews and Meyer,  1993; Rogister et al.,  1993).  By using a 
bioassay, we also determined the amount of total vs active 
TGF-/$  for each isoform. In each case, the majority of the 
TGF-/3  detected  was  latent,  with  active levels in  the  3-5 
pg/ml range.  This concentration  of TGF-/~  has  significant 
biological effects in many systems (reviewed briefly in Abe 
et  al.,  1994).  Whether  these  levels  are  biologically  sig- 
nificant  for  Schwann  cells  is  not  yet  dear.  It should  be 
noted that we have measured the amount of TGF-/$ present 
in the culture media, and we do not yet know whether this 
accurately reflects the levels of TGF-/$ associated with the 
cells and their extracellular matrix. Moreover, the concen- 
The Journal of Cell Biology, Volume  129, 1995  454 Figure 8. Expression of TGF-~ receptors in cocultures. Iodinated 
TGF-/31 was cross-linked to cultures of neurons alone (lanes a and 
b) or heavily myelinated neuron/Schwann  cell cocultures (lanes c 
and d) in the absence (lanes a and c) or presence (lanes b and d) 
of an excess of  unlabeled TGF-~. Cell lysates were prepared, frac- 
tionated by SDS-PAGE, and  they were exposed with a  Phos- 
phorlmager. The major bands that are visible in the myelinating 
cocultures correspond in size to the three major classes of TGF-~ 
receptors as indicated to the right; molecular weight markers are 
provided on the left. 
tration of TGF-•  present in the periaxonal space could be 
higher than the amounts detected in the media, particularly 
if TGF-/5 is released into this site by neurons or Schwann 
cells, as may be the case for other growth factors, notably 
acidic FGF that has been localized immediately subjacent 
to the axolemma (Elde et al., 1991). Immunolocalization of 
TGF-/3 and its receptors should clarify this issue. 
It is of particular interest that there is a specific decrease 
in the amount of TGF-~I in the conditioned media from the 
cocultures, particularly in comparison to the Schwann cell 
cultures. By contrast, TGF-ff2  levels in the cocultures re- 
main essentially unchanged and TGF-/33 levels may even in- 
crease in comparison to the  Schwann cell cultures.  This 
reduction in the amount of TGF-81  occurs despite the in- 
creased number of cells present in the cocultures (i.e., both 
neurons and Schwann cells).  Also,  this decrease was ob- 
served  in  cocultures  maintained  without  ascorhic  acid, 
which  therefore lacked a  basal  lamina to  which  TGF-/31 
might bind. These results indicate that expression of TGF-~I 
is reduced as a result of neuron/Schwann cell interactions. 
Strong support that TGF-BI  levels are indeed regulated by 
Schwann cell/neuron interactions was provided by a recent 
report that TGF-/51 mRNA levels increase dramatically after 
sciatic nerve crush, and that they fall again as nerve fibers 
regenerate and contact the Schwann cells again (Scherer et 
al.,  1993);  interestingly, a  converse pattern of expression 
was noted for TGF-/53. Similarly, TGF-131 protein levels were 
noted to increase substantially at the site of sciatic nerve 
crush by immunocytochemistry (Register et al.,  1993).  Fi- 
nally,  treatment  of Schwann  cells  with  forskolin,  which 
mimics many of the effects of axonal contact, downregulates 
the expression of TGF-/31 (Mews and Meyer, 1993; Scherer 
et al., 1993).  Taken together, these findings indicate that ex- 
pression of'IGF-/31 by the Schwann cell is significantly and 
specifically downregulated by axons, and that it increases 
substantially after peripheral nerve injury. As will be dis- 
cussed further, these findings and the effects of TGF-/31 on 
Schwann cells support a role for TGF-B1 during Wallerian 
degeneration. 
TGF-[3 Has Dual Effects on Schwann Cell 
Proliferation That Depend on Neuronal Contact 
TGF-BI and -/32 were previously reported to be Schwann cell 
mitogens (Eccleston et al., 1989; Ridley et al., 1989; Davis 
and Stroobant, 1990; Schubert, 1992; Register et al., 1993) 
in contrast to their inhibition of cell proliferation in many 
other cell types (Massagut, 1990; Sporn and Roberts, 1992). 
We have confirmed these results, observing an approximate 
seven-fold increase in the labeling index of Schwann cells 
treated with TGF-B1. It is not yet known whether TGF-/3 acts 
directly as a mitogen or,  alternatively, promotes Schwann 
cell proliferation by inducing expression of another growth 
factor, as has been reported in the case of its mitogenic effect 
on aortic endothelial cells (Leof et al.,  1986).  In striking 
contrast to its mitogenic effect on purified Schwann cells, we 
found that TGF-B1 is a potent inhibitor of the Schwann cell 
proliferation engendered by neurons. Because Schwann cells 
are normally quiescent unless they are in contact with axons 
(Wood and Bunge,  1975;  Salzer et al.,  1980),  this TGF-/3 
effect  could  reflect  a  direct  inhibition  of  Schwann  cell 
proliferation or, an indirect effect, i.e., interfering with the 
ability of the axon to deliver its mitogenic signal. The rapid 
inhibition of proliferation in the Schwann cell/neuron cocul- 
tures and the apparent lack of significant numbers of TGF-/3 
receptors on neurons, however,  suggest that this is a direct 
effect  on Schwann cell proliferation and is not caused by inhi- 
bition of the expression of the neuronal mitogen. These re- 
sults also emphasize that the response of Schwann cells to 
polypeptide growth factors can dramatically differ depend- 
ing on their association with nerve fibers. 
TGF-[3 Regulated Schwann Cell Differentiation 
A major finding of this study is that TGF-/3 appears to drive 
Schwann cells towards a non- or premyelinating phenotype, 
inhibiting the expression of the p75 NGF receptor and par- 
tially blocking the forskolin mediated induction of P0. These 
findings confirm recent  reports  that  TGF-/5'I inhibits p75 
NGF receptor mRNA (Mews and Meyer, 1993; Register et 
al.,  1993),  as well as the forskolin induction of P0 protein 
and mRNA (Mews and Meyer, 1993; Morgan et al., 1994). 
The effects of TGF-/~I on cell adhesion molecule expression 
by Schwann cells are more complex. We found that TGF-/~ 
treatment of Schwann cells results in a consistent increase in 
NCAM expression that ranged from 1.6-fold in the presence 
of serum to 6-fold in serum-flee media (Table 1). By con- 
trast,  TGF-/5'I, particularly  at  high  concentrations in  the 
presence of serum,  significantly suppressed L1 expression 
whereas at low concentrations in defined media, TGF-#I had 
a  minimal or even a  stimulatory effect on L1  expression. 
These latter results may be compared to previous reports that 
TGF-/~I  increases  the  expression  of NCAM  protein  and 
mRNA  by  two-  to  three-fold  in  the  3T3  fibroblast  line 
(Roubin et al.,  1990),  and that it upregulates L1, but not 
NCAM, protein and mRNA in a population of postnatal mu- 
rine cerebellar glial cells (Saad et al., 1991). Taken together, 
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adhesion molecule expression that vary by cell type, and they 
demonstrate that expression of NCAM and L1 can be in- 
dependently regulated in Schwann cells. Although we have 
not specifically investigated the functional significance of  the 
changes in cell adhesion molecule expression induced by 
TGF-B, we have noted that treated Schwarm ceils tend to ag- 
gregate more readily after trypsinization than control cells 
(Einheber, S., and J. Salzer, unpublished observations), sug- 
gesting that TGF-~I promotes adhesive interactions. 
We have also characterized the effects of TGF-BI on the 
expression of the Schwann cell transcription factor SCIP. 
TGF-ffl increased SCIP expression from two- to eight-fold 
in the presence of 1 or 10 ng/ml of TGF-BI,  respectively. 
Since SCIP expression has been correlated with the premye- 
linating phenotype (Monuki et al., 1990), these results pro- 
vide additional evidence that TGF-~I promotes the transition 
of Schwann cells to an early, nonmyelinating phenotype. 
TGF-~,  together  with  agents  that  elevate  intracellular 
cAMP,  represent  independent  mechanisms  for  elevating 
SCIP expression in Schwann cells. However, although both 
TGF-/31 and forskolin induce SCIP expression, they have 
contrasting effects  on the  Schwann  cell  phenotype,  with 
TGF-BI suppressing and forskolin promoting the myelinat- 
ing phenotype. Because SCIP has been demonstrated to re- 
press transcription of the P0 and NGF receptor promoters 
(Monuki et al., 1990; He et al., I991), these findings raise 
the possibility that the inhibition of P0 and NGF receptor ex- 
pression by TGF-BI is related to this increased SCIP expres- 
sion. (The effect of TGF-B1 on SCIP does not explain its abil- 
ity to antagonize the forskolin induction of P0 expression, 
since SCIP levels in Schwann calls treated with both forsko- 
lin and TGF-BI were lower on average than the levels in cells 
treated with forskolin alone.) The relationship of this in- 
crease in SCIP expression, if any, to the observed changes 
in NCAM and L1 levels, remains to be determined. 
TGF-{31 Inhibits Schwann Cell Myelination and Basal 
Lamina Formation 
One of the most dramatic findings of this paper, the essen- 
tially complete inhibition of myelination in the cocultures 
treated with TGF-~I and -~2, also supports a role for TGF-/~ 
in promoting a pre- or nonmyelinating phenotype. Thus, in 
the presence of 1 ng/rnl, there is a substantial reduction in 
the extent of  myelination, and at 10 ng/ml of  TGF-ffI and -/~2, 
there is a complete inhibition of myelination. The inhibitory 
effect of "I'GF-/31 appears to require its presence during the 
period of active myelination; pretreatrnent of Schwann cells 
with TGF-ffl, or treatment with TGF-ffl after myelin seg- 
ments had already formed, appeared to have minimal effects 
on myelination. This inhibition is likely to be a direct effect 
of TGF-fl on the Schwann cell rather than an indirect effect 
on the neuron. This is consistent with the high level expres- 
sion of TGF-~t receptors by myelinating Schwann cells, but 
not by neurons (see Fig. 8), and the striking effects of TGF-/3 
on Schwarm cell proliferation and cell adhesion molecule 
expression in contrast to any obvious effects on neurons. 
The mechanism by which TGF-~ inhibits myelination by 
Schwann cells is not yet known. We observed that although 
no myelin segments form in the treated cocultures, Schwann 
cells display detectable and particulate staining for MBP 
(see Fig. 3 E). This result suggests that MBP, and perhaps 
other myelin components, may continue to be synthesized at 
low levels in the presence of  TGF-B, but cannot be assembled 
into a myelin sheath. Additional studies will be required to 
clarify this point. 
We have also found that TGF-ffl inhibits assembly of the 
basal lamina. In particular, the basal lamina appeared patchy 
and thin in cocultures treated with TGF-B in comparison to 
untreated cultures (see Fig. 4). These findings are also sup- 
ported  by  the  attenuated  laminin  staining  and  reduced 
amount of laminin detected in the treated cultures. The inhi- 
bition of Schwann cell proliferation by TGF-~ with the con- 
sequent reduction in the number of Schwann cells may have 
accentuated this reduction). Of note, the major laminin iso- 
form in these cultures is not laminin-1,  but appears to be 
laminin-2 and/or laminin-4, consistent with previous studies 
on the expression of these isoforms in peripheral nerve in 
vivo (Sanes et al.,  1990).  These effects of TGF-~I on the 
Schwann cell basal lamina appear to contrast with its effects 
on  Schwann cells  grown alone.  Specifically,  TGF-BI  has 
been reported to increase the expression of collagen type IV, 
but not laminin, mRNAs by adult Schwann cells and to de- 
crease the secretion of tissue-type plasminogen activator and 
increase  the  secretion  of  PAI  by  adult  Schwann  cells 
(Rogister et al., 1993). These results suggest that it promotes 
extraceUular matrix accumulation in purified populations of 
Schwann cells. Thus, the effect of TGF-B1 on the synthesis 
of the Schwann cell extracellular matrix may also depend on 
axonal interactions. 
It should be noted that, because TGF-I3 has pleiotropic 
effects on Schwann cells, including effects on proliferation 
and basal lamina production, the inhibition of myelination 
may be multifactorial. Nevertheless, we were able to distin- 
guish  the  inhibitory effects of TGF-B1 on  Schwann  cell 
proliferation and basal lamina production from those on my- 
elination by seeding excess Schwann cells on neurons and by 
adding TGF-B1 to the cocultures after a basal lamina had 
formed, respectively.  In addition, the ability of TGF-B1 to 
antagonize the forskolin-mediated induction of P0 protein 
(see Fig. 2) and mRNA in Schwann cells maintained under 
culture conditions that preclude basal lamina formation and 
proliferation (Morgan et al., 1994), also argues that TGF-BI 
can directly inhibit Schwann cell differentiation into the my- 
elinating phenotype. 
The Potential Role of TGF-[31 in Development 
and Degeneration 
These studies raise the possibility that TGF-ffl may function 
as a  negative regulator of Schwann cell proliferation and 
differentiation during peripheral nerve development. Poten- 
tiaUy, once an appropriate complement of cells is generated, 
TGF-/3 could terminate further proliferation of Schwann 
cells and/or maintain Schwann cells in an ensheathing state 
in unmyelinated nerves. We do not favor this model for sev- 
eral reasons. In the studies reported here, rather than finding 
an increase in the levels of TGF-~ in the mature cocultures 
at a time when Schwann cell proliferation is markedly re- 
duced, we observed the reverse. In addition, anti-TGF-fl an- 
tibodies that neutralize all three isoforms of TGF-B had no 
discernible effect on Schwann cell proliferation in the eocul- 
ture system (Lin, J., and J.  Salzer,  unpublished observa- 
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ber of myelinated fibers that formed when Schwann cells 
were cocultured with either sensory or sympathetic neurons. 
Rather, we suggest that during development, expression of 
TGF-/31 is normally downregulated as a result of axonal con- 
tact,  thereby allowing Schwann cell proliferation and dif- 
ferentiation to progress. 
The regulated expression of TGF-/31 and its effects do sug- 
gest a  role for TGF-Aq during Wallerian degeneration. As 
noted, TGF-~I levels increase dramatically after peripheral 
nerve injury (Rogister et al., 1993; Scherer et al., 1993). In 
addition, many of the changes that occur in Wallerian de- 
generation  are  consistent  with  the  effects  of TGF-/3 on 
Schwann cells (see also discussion in Scherer et al.,  1993). 
Thus, an increase in TGF-/3 would be expected to induce 
proliferation of isolated Schwann cells in the distal stump 
and increase their expression of NCAM, although perhaps 
not L1. Also, the increase in TGF-/31 levels that accompany 
Wallerian degeneration may account for the modest, tran- 
sient increase in SCIP expression that has been observed sev- 
eral  days after  nerve  transection  (Monuki  et  al.,  1990; 
Scherer et al., 1994). In addition, TGF-/~ is chemotactic for 
macrophages (Wahl et al.,  1987);  its increase during Wal- 
lerian degeneration would therefore be expected to promote 
infiltration of macrophages into the distal stump.  Macro- 
phages release interleukin-1 in response to TGF-/~ (Wahl et 
al.,  1987)  which,  in turn,  has been implicated in the in- 
creased expression of NGF and the NGF receptor by non- 
neuronal cells during Wallerian degeneration (see Brown et 
al., 1991; Matsuoka et al., 1991). Macrophages may further 
amplify the response to TGF-/~I by activating latent TGF-/31 
(Wahl,  1992), as well as releasing other soluble factors that 
are  mitogenic for Schwann cells (Baichwal et al.,  1988). 
TGF-~l promotes the survival of motor and sensory neurons 
(Martinou et al.,  1990; Chalazonitis et al., 1992),  suggest- 
ing it may have neurotrophic activity itself. Finally, TGF-B 
stimulates the synthesis of tenascin-C by fibroblasts (Pearson 
et al.,  1988;  Tucker et al.,  1993),  an extracellular matrix 
component that regulates nerve fiber outgrowth and that is 
known to increase after peripheral nerve injury (Martini et 
al.,  1990). 
These effects of TGF-/31 may be important to the ability 
of nerve fibers to regenerate in the peripheral nervous sys- 
tem. Myelinated nerve fibers (Bedi et al., 1992) and myelin 
components such as MAG (Mukhopadhyay et al., 1994) are 
nonpermissive substrates for the regeneration of adult neu- 
rons. By recruiting macrophages, which scavenge myelin de- 
bris (Stoll et al., 1989; Brown et al., 1991), and by promot- 
ing the transition of Schwann cells from a myelinating to a 
nonmyelinating phenotype, increased TGF-/31 levels  would 
be expected to enhance nerve fiber regeneration in the distal 
stump. Elevated levels of TGF-/~I might also delay myelina- 
tion in the distal stump as nerve fibers begin to grow back, 
thereby preventing the generation of a  nonpermissive sub- 
strate. Once a full complement of nerve fibers have grown 
back into the distal stump, TGF-/51 is downregulated (Scherer 
et al., 1993), presumably allowing subsequent ensheathment 
and myelination to ensue. By contrast, TGF-~l does not ap- 
pear to cause breakdown of myelin that has already formed 
(data not shown) or to induce the proliferation of Schwann 
cells already associated with neurites. The apparent absence 
of effects on mature myelin sheaths may ensure that unin- 
jured fibers proximal to the site of injury, or in close prox- 
imity in the case of a partial nerve injury, are not adversely 
affected by TGF-B. 
In summary, we have provided evidence that TGF-~ has 
profound effects on axon/Schwann cell interactions that differ 
from its effects on Schwann cells alone. These data suggest 
an important role for TGF-B in the regenerative responses 
that follow peripheral nerve injury, as well as a possible role 
as a  negative regulator of Schwann cell proliferation and 
differentiation during development. 
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Note Added in Proof. A similar inhibitory effect of TGF-/~ on Schwann cell 
myelination in vitro was recently reported (Gudnard, V., L. A. Gwynn, and 
P. Wood.  1995.  J.  Neurosci.  15:419-428). 
~eference$ 
Abe, M., J. G. Harpel, C. N. Metz, 1. Nunes, D. J. Loskutoff, and D. B. Rifkin. 
1994. An assay for transforming growth factor-# using cells transfected with 
a  plasminogen activator  inhibitor-I  promoter-luciferase construct.  Anal. 
Biochem.  216:276-284. 
Aguayo, A. J., J. Epps, L. Charron, and G. M. Bray. 1976.  Multipotentiality 
of Schwann cells in cross-anastomosed and grafted myelinated and unmy- 
elinated nerves: quantititive microscopy and radioautography. Brain Res. 
104: 1-20. 
Baichwal,  R.  R.,  J.  W.  Bigbee,  and  G.  H.  DeVries.  1988.  Macrophage- 
mediated myelin-relalexl mitogenic factor for cultured Schwann cells. Proc. 
Natl. Acad.  Sci. USA. 85:1701-1705. 
Bedi,  K. S., J. Winter, M. Berry, and J. Cohen. 1992.  Adult rat dorsal root 
ganglion neurons extend neurites on predegenerated but not on normal pe- 
ripheral  nerves in vitro. Fur. J.  Neurosci.  4:193-200. 
Beuche, W., and R. L. Friede. 1984. The role of non-resident  cells in Wallerian 
degeneration. J,  Neurocytol.  13:767-796. 
Bolin, L. M., and E. M. Shooter. 1993. Neurons regulate Schwann cell genes 
by diffusible molecules. J.  Cell Biol. 123:237-243. 
Brown, M. C., V. H. Perry, E. R. Lunn, S. Gordon, and F. Heumann. 1991. 
Macrophage dependence of peripheral sensory nerve regeneration: possible 
involvement of nerve growth factor. Neuron.  6:359-370. 
Bunge, M. B., A. K. Williams, and P. M. Wood. 1982. Neuron-Schwann cell 
interaction in basal lamina formation. Dev. BioL 92:449--460. 
Bunge, R. P., M. B. Bunge, and C. F. Eldridge. 1986. Linkage between axonal 
ensheathment and basal lamina production by Schwann cells. Annu. Rev. 
Neurosci.  9:305-328. 
Chalazonitis, A., J. Kalberg, D. R. Twardzik, R. S. Morrison, and J. A. Kess- 
ler.  1992. Transforming growth factor/3 has neutrotrophic actions on sen- 
sory neurons in vitro and is synergistic with nerve growth factor. Dev. Biol. 
152:121-132. 
Davis, J.  B.,  and  P.  Stroobant.  1990.  Plate|et-derived growth factors and 
fibroblast  growth factors are mitogens for rat Schwann cells. J.  Cell Biol. 
110:1353-1360. 
Eccleston, P. A., K. R. Jessen, and R. Mirsky.  1989.  Transforming growth 
factor-beta and gamma-interferon have dual effects on growth of peripheral 
glia. J. NeuroscL Res.  24:524-530. 
Einheber, S., T. Milner, F. Giancotti, and J. Salzer.  1993. Axonal regulation 
of Schwann cell integrin expression suggests a role for alpha6 beta4 in my- 
elination. J.  Cell Biol. 123:1223-1236. 
Elde, R., Y. Cao, A. Cintra, T. C. Brelje,  M. Pelto-Huikko, T. Junttila, K. 
Fuxe, R. F. Pettersson and T. H6kfelt. 1991. Prominent expression of acidic 
fibroblast growth factor in motor and sensory neurons. Neuron. 7:349-364. 
Fawcett, J. W., and R. J. Keynes. 1990. Peripheral nerve regeneration. Annu. 
Rev. Neurosci.  13:43-60. 
Fernandez-Vail6, C., N. Fregien, P. M. Wood, and M. B. Bunge. 1993. Ex- 
pression of the protein zero myelin gene in axon-related Schwann cells is 
linked to basal lamina formation. Development  (Camb.).  119:867-880. 
Flanders, K. C., G. L. Liidecke,  S. Engels, D. S. Cissel, A. B. Roberts. P. 
Einheber et al.  TGF-~ 1 Regulates Axon/Schwann  Cell Interactions  457 Kondaiah, R. La~atis, M. B. Sporn, and A. Unsicker. 1991.  Localization 
and actions of transforming growth factor-as in the embryonic nervous sys- 
tem.  Development  (Camb.).  113:183-191. 
He, X., R. Gerrero, D. M. Simmons, R. E. Park, C. R. Lin, L. W. Swanson, 
and M. G. Rosenfeld. 1991. Tst-i, a member of the POU domain gene fam- 
ily, binds the promoter of the gene encoding the cell surface adhesion mole- 
cule P0. Idol  Cell BioL 11:1739-1744. 
He, X., M. N. Treacy, D. M. Simmons, H. A. Ingrsham, L. W. Swanson, and 
M. G. Roseofeld. 1990. Expression  of a large family of POU-domain regula- 
tory genes in mammalian brain development. Nature (Lond.). 340:35-42. 
Jessen, K. R., and R. Mirsky. 1991. Schwann cell precursors and their develop- 
ment.  Gila. 4:185-194. 
Kingsley, D. M. 1994. The TGF-B superfamily: new members, new receptors, 
and new genetic tests of function in different  organisms. Genes & Devel. 
8:133-146. 
Lemke, G., and M. Chad.  1988.  Axons regulate Schwann cell expression of 
the major myelin and NGF receptor genes. Development  (Camb.).  102: 
499-504. 
Leof, E. B., J. A. Proper, A. S. Goustin, G. D. Shipley, P. E. DiCorletto, and 
H. L. Moses. 1986. Induction ofc-ds mRNA and activity similar to platelct- 
derived growth factor by transforming growth factor-B.  Proc. Natl. Acad. 
Sci.  USA. 8:2453-2457. 
Marchionni,  M.  A.,  A.  D.  J.  Goodearl,  M.  S.  Chen,  O.  Barmingham- 
McDonogh, C. Kirk, M. Hendricks, F. Danehy, D. Misumi, J. Sudhalter, 
K. Kobayashi, et al.  1993.  Glial  growth factors are alternatively spliced 
erbB2 ligands expressed in the nervous system. Nature  (Lond.). 362:312- 
318. 
Martini, R., and M. Schachner. 1988.  Immunoelectron microscopic localiza- 
tion of neural cell adhesion molecules (LI, N-CAM, and myelin-associated 
glycoprotein)  in  regenerating  adult  mouse sciatic  nerve.  J.  Cell Biol. 
106:1735-1746. 
Martini, R., M. Schachner, and A. Faissner. 1990. Enhanced expression of the 
extracellular matrix molecule Ji/tenascin in the regenerating adult mouse 
sciatic nerve. J.  Neurocytol.  19:601-616. 
Martinou, J. C., A. L. V. Thai, A. Valette, and M. J. Weber. 1990. Transform- 
ing growth factor BI is a potent survival factor for rat embryo motorneurons 
in culture. Dev. Brain Res.  52:175-181. 
Massagu~, J.  1990.  The transforming growth factor-beta  family. Annu. Rev. 
Cell Biol. 6:597-641. 
Matsuoka, I., M. Meyer, and H. Thoenen. 1991. Cell-type-specific  regulation 
of nerve growth factor (NGF) synthesis in non-nenronal cells: comparison 
of Schwann cells with other cell types. J. Neurosci.  11:3165-3177. 
Mews, M., and M. Meyer.  1993.  Modulation of Schwann cell phenotype by 
TGF-/~l: inhibition of P0 mRNA expression and downregulatiou of the low 
affinity NGF receptor.  Glia. 8:208-217. 
Milner, T. A., and C. E. Bacon.  1989.  GABA-ergic neurons in the rat hip- 
pocampal formation: Ultrastructure and synaptic relationships with catechol- 
aminergic terminals. J.  Neurosci. 9:3410-3427. 
Mouuki, E. S., R. Knhn, G. Weinmaster, B. D. Trapp, and G. Lemke. 1990. 
Expression and  activity of the POU transcription  factor  SCIP.  Science 
(Wash. DC). 249:1300-1303. 
Mouuki, E. S., G_ Weinmaster, R. Kuhn, and G. Lemke. 1989. SCIP:  a glial 
cell  POU domain gene regulated by cyclic AMP. Neuron.  3:783-793. 
Morgan, L.,  K. R. Jessen, and R. Mirsky.  1991.  The effects of cAMP on 
differentiation  of cultured Schwann cells: progression from an early pheno- 
type (04+) to a myelin phenotype (P0+, GFAP-, N-CAM-, NGF-receptor-) 
depends on growth inhibition.  J.  Cell Biol. 112:457-467. 
Morgan, L., K. R..lessen, and R. Mirsky.  1994.  Negative regulation of the 
P0 gent in Schwann cells: suppression of PO mRNA and protein induction 
in cultured Schwann cells by FGF2 and TGF/31, TGF/T2, TGFB3. Develop- 
merit (Camb.).  120:1399-1409. 
Moya, F., M. B. Bunge, and R. P. Bunge. 1980. Schwann cells proliferate  but 
fail  to  differentiate  in  defined  medium.  Proe.  Natl. Acad. Sci. USA. 
77:6902-6906. 
Mukhopadhyay, G., P. Doherty, F. S. Walsh, P. R. Crocker, andM. T. Fiibin. 
1994. A novel role for myelin-associated glycoprotein as an inhibitor of ax- 
onal regeneration. Neuron.  13:757-767. 
Owens, G. C., and R. P. Bunge. 1989. Evidence for an early role for myelin- 
associated glycoprotein in the process of myelination. Gila. 2:119-128. 
Pearson, C. A., D. Pearson, S. Shibahara, .l.  Hofgsteenge, and R. Chiquet- 
Ehrismann. 1988. Tenascin: cDNA cloning and induction by TGF-B. EMBO 
(Fur. Mol. Biol. Organ.)J.  7:2977-2981. 
Peles, E.,and Y. Yarden. 1993. Neu and its ligands: from an oncogene to neu- 
ral factors. BioEssays.  15:815-824. 
Porter,  S.,  M. B. Clark, L. Glaser, and R. P. Bunge. 1986.  Schwann cells 
stimulated to proliferate in the absence of neurons retain full functional capa- 
bility.  J. Neurosci.  6:3070-3078. 
Ridley, A. J., J.  B. Davis, P. Stroobant, and H. Land.  1989.  Transforming 
growth factors-Bl and B2 are mitogens for rat Schwann cells. J.  Cell Biol. 
109:3419-3424. 
Rogister, B., P. Delree, P. Lcprince, D. Martin, C. Sadzot, B. Malgrange, C. 
Munant, J. M. Rigo, P. P. Lefebvre, J. Octave, J. Schoenen, and G. Moo- 
hen. 1993. Transforming growth factor beta as a neuronoglial signal during 
peripheral nervous system response to injury. J. Neurosci. Res. 34:32--43. 
Ronhin, R., B. H. Dengostini, M. R. Hirsch, andC. Goridis. 1990. Modulation 
of NCAM expression by transforming growth factor-hera,  serum, and auto- 
crine factors. J.  Cell Biol. 111:673-684. 
Saad, B., D. B. Constam, R. Ortmann, M. Moos, A. Fontana, and M. Schach- 
net. 1991. Astrocyte-derived  TGF-B'2 and NGF differentially  regulate neural 
recognition  molecule  expression  by  cultured  astrocytes.  J.  Cell Biol. 
115:473-484. 
Salzer, J. L., and R. P. Bunge. 1980.  Studies of Schwann cell proliferation. 
I.  An  analysis  in  tissue  culture  of  proliferation  during  development, 
Wallerian degeneration, and direct injury. J.  Cell Biol.  84:739-752. 
Salzer, J.  L.,  R. P.  Bunge, and L. Glaser.  1980.  Studies of Snhwann cell 
proliferation. II1. Evidence for the surface localization  of the neurite mito- 
gen. J.  Cell Biol. 84:767-778. 
Salzer, L  L. 1995. Mechanisms of adhesion between axons and glial cells. In 
The Axon. S. Waxman, J. Kocsis, and P. Stys, editors. Oxford University 
Press, New York. pp.  164-184. 
Sanes, J. R., E. Engvall, R. Butkowski, and D. D. Hunter.  1990. Molecular 
heterogeneity of basal laminae: isoforms of laminin and collagen IV at the 
neuromuscular  junction and elsewhere. J.  Cell Biol. 11 i: 1685-1699. 
Scherer, S. S., and A. K. Asbury. 1993. Inherited axonal neuropathies. In The 
Molecular and Genetic Basis  of Neurologic Disease. R. N. Rosenberg, S. B. 
Prosiner,  S.  DiMauro,  R.  L  Barehi,  and  L.  M.  Kankel,  editors. 
Butterworth-Heinemann, Stoneham, MA. pp. 899-921. 
Scherer, S. S., J. Kamhoiz, and S. B. Jakowlew.  1993. Axons modulate the 
expression of transforming growth factor-betas in  Schwann ceils.  Glia. 
8:265-276. 
Scherer, S. S., D. Wang, R. Kuhn, G. Lemke, L. Wrabetz, and J. Kamholz. 
1994. Axons regulate Schwann cell expression of the POU transcription fac- 
tor SCIP. J. Neurosci.  14:1930-1942. 
Schubert, D. 1992. Synergistic interactions between transforming  growth factor 
beta and fihrohlast growth factor regulate Schwann cell mitosis. J.  Neu- 
robiol. 23:143-148. 
Sporn, M. B., and A. B. Roberts. 1992. Transforming growth factor-beta:  re- 
cent progress and new challenges. J.  Cell Biol. 119:1017-1021. 
Stoll, G., J. W. Griffin, C. Y. Li, and B. D. Trapp. 1989. Wallerian degenera- 
tion in the peripheral nervous system: participation  of both Snhwann cells 
and macrophages in myelin degradation. J. Neurocyt.  18:671-683. 
Suzuki, N., H. Rohdewohld, T. Neuman, P. Gruss, and H. R. Scholer. 1990. 
Oct-6:  a POU transcription factor expressed in embryonal stem cells and in 
the developing brain. EMBO (Ear. Mol. Biol. Organ.) J. 9:3723-3732. 
Tucker, R. P., J. A. Hammarback, D. A. Jenrath, E. J. Maclde, and Y. Xu. 
1993. Tenascin expression in the mouse: in situ localization  and induction 
in vitro by bFGF. J.  Cell Sci. 104:69-76. 
Unsicker, K., K. C. Flanders, D. S. Cissel, R. Lafyatis, and M. B.  Sporn. 
1991. Transforming growth factor beta isoforms in the adult rat central and 
peripheral nervous system. Neuroscience. 44:613-625. 
Wahl, S. M. 1992. Transforming growth factor beta (TGF-B) in inflammation: 
a cause and a cure J.  Clin lmmunol.  12:61-74. 
Wahl, S. M., D. A. Hunt, L. M. Wakefield, N. McCartney-Francis, L. M. 
Wahl, A. B. Roberts, and M. B. Sporn.  I987. Transforming growth factor 
type b induces monocyte chemotaxis and growth factor production. Proc. 
Natl. Acad. Sci. USA. 84:5788-5792. 
Wang, X., H. Lin, E. Ng-Eaton, J. Downward, H. Lodish, and R. Weinberg. 
1991.  Expression cloning and characterization of the TGF-beta type III 
receptor.  Cell. 67:797-805. 
Webster, H. D.  1992.  Development of peripheral nerve fibers.  In Peripheral 
Neuropathy. 3rd ed. P. J. Dyck, P. K. Thomas, J. Griffin,  P. A. Low, and 
J. F. Poduslo, editors. W. B. Sannders Co., Philadelphia.  pp. 243-266. 
Weinberg, H. J., and P. S. Spencer. 1976. Studies on the control of myelino- 
genesis. II. Evidence for neuronal regulation of myelin production. Brain 
Res.  113:363-378. 
Wen, J.  Y.  M., C.  M.  Morshead, and D.  v. d.  Kooy.  1994.  Satellite  cell 
proliferation  in the adult rat trigeminal ganglion results from the release of 
a  mitogenic protein from explanted sensory neurons. J.  Cell Biol.  124: 
1005-1015. 
Wood, P. M., and R. P. Bunge. 1975. Evidence that sensory axons are mito- 
genic for Schwann cells. Nature (Lond.). 256:662-664. 
The Journal of Cell Biology,  Volume 129,  1995  458 